Home › Stocks › ABEO › All Fund Holders
ABEO — ABEONA THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 34 · Reported value held: $82.16M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 3.35M | $20.72M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 2.76M | $14.53M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 1.26M | $7.80M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 1.22M | $7.57M | 0.00% | Add |
| Point72 Asset Management history | Q4 2023 | 760.87K | $3.81M | 0.01% | Reduce |
| Northern Trust Corp history | Q2 2026 | 552.63K | $3.42M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 548.30K | $3.39M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 454.40K | $2.81M | 0.00% | Add |
| Balyasny Asset Management history | Q1 2026 | 589.85K | $2.64M | 0.00% | Hold |
| Bank of America Corp history | Q2 2026 | 372.41K | $2.30M | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 365.56K | $2.26M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 223.28K | $1.38M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 211.34K | $1.31M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 204.25K | $1.26M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 194.83K | $1.20M | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 138.50K | $855.91K | 0.00% | Reduce |
| Wellington Management Group history | Q3 2025 | 150.93K | $796.90K | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 120.51K | $744.78K | 0.00% | Reduce |
| Renaissance Technologies history | Q1 2026 | 161.08K | $721.65K | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 80.74K | $498.95K | 0.00% | New |
| AQR Capital Management history | Q2 2026 | 67.06K | $414.45K | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 57.10K | $352.88K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 47.56K | $293.91K | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 50.51K | $285.86K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 36.59K | $226.11K | 0.00% | Add |
| Prudential Financial history | Q3 2025 | 37.31K | $197.00K | 0.00% | New |
| Invesco Ltd history | Q2 2026 | 23.72K | $146.61K | 0.00% | Add |
| Franklin Resources history | Q1 2022 | 325.00K | $102.00K | 0.00% | Hold |
| Manulife Financial history | Q2 2026 | 12.24K | $75.67K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 3.98K | $24.57K | 0.00% | Hold |
| Principal Global Investors history | Q3 2021 | 19.57K | $22.00K | 0.00% | New |
| PNC Financial Services history | Q2 2026 | 569 | $3.52K | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 32.59K | $202 | 0.00% | Add |
| Lazard Asset Management history | Q4 2024 | 116 | $0 | — | Hold |